Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Effect of Biofeedback-Based Inertial Sensors Gait Training on Walking Parameters in Children With Hemiplegia

1. juli 2026 oppdatert av: Naglaa Ezzat Abd Allah Mahmoud, Cairo University

The goal of this clinical trial is to learn about the effect of biofeedback-based inertial sensors gait training on walking parameters in children with hemiplegia. The main question it aims to answer is:

Does biofeedback-based inertial sensors gait training have an effect on walking parameters in children with hemiplegia.

  • Participants in the study and control groups will receive 30 minutes designed physical therapy program, three times per week for three successive months.
  • Children in the control group will receive traditional gait training for 30 minutes, three times per week for three successive months.
  • Children in the study group will receive 30 minutes biofeedback-based inertial sensors gait training session three times per week for three successive months.

Studieoversikt

Detaljert beskrivelse

  • The current study is randomized controlled trial (RCT).
  • Thirty children with spastic hemiplegic CP of both sexes (8to 12 years) will be selected from Outpatient Clinic of Faculty of Physical Therapy, Cairo University.
  • Children will be randomly assigned into two groups; group A (control) and group B (study).
  • Children in both groups will receive traditional physical therapy program for 30 minutes, three times per week for three successive months. In addition, children in group A will receive traditional gait training for 30 minutes while children in group B will receive gait training using Steadys system for 30 minutes.
  • Instrumentation for patient selection include:

    1- Modified Ashworth' Scale: Spasticity of children participating in this study will be ranged from 1 to 1+. 2- The Gross Motor Function Classification System (GMFCS): Children participating in this study will be level I or II on GMFCS.

  • Instrumentation for Evaluation include:

    1. Steadys Software System

The Steadys system primary components and adjustment mechanisms include:

  1. The Neurosens inertial measurement units (IMU) sensors
  2. Treadmill
  3. BFB Monitor
  4. Record
  5. Patient folder
  6. Report For Treatment

Children in each group will receive 30 minutes designed physical therapy program, three times per week for three successive months. Each session will consist from the following:

  • Mat activities: standing up from sitting, kneeling and half kneeling.
  • Activities while standing: weight bearing exercises, single leg balance with bar, and balance exercise with different floor styles.
  • Training righting, equilibrium a protective reactions from standing. Control group

Children in this group will receive traditional gait training for 30 minutes, three times per week for three successive months. Each gait training session will consist from the following:

  • Walking on balance beam - Walking on balance board
  • walking over stepper - Gait training using separator Study group

Children in this group will receive 30 minutes BFB gait training session three times per week for three successive months. The gait training steps will be as follows:

  • Each child with the attached sensors will stand on the treadmill, which will be turned on and set to a speed comfortable for the child then the child's gait data will be acquired by the IMU sensors and transferred to PC via Wi-Fi to be converted to the easy-to-read displays.
  • The child will be asked to look at the BFB monitor while walking on the treadmill.
  • Instructions will be given to the child to correct the abnormal walking pattern based on the visual and auditory feedback that will be provided through the BFB monitor.
  • The abnormal gait parameter will be visualized on the monitor and played back as audio cues to ensure the feedback.
  • The feedback is shown as interaction with virtual walking environment.
  • During the session, the selected parameter will be displayed as columns with a marked specified range of change. An out-of-range value shown as an error and causes a slowdown in the movement around the virtual environment and in the completion of the set task. Depending on the virtual environment used, there will be also other details reflecting the test performance. The automatic training algorithm will be configured such that in the case of a successful completion, the range of change will be adjusted towards greater symmetry of the parameters.
  • Based on the obtained BFB, the patient changes his/her gait pattern to improve it.

Studietype

Intervensjonell

Registrering (Antatt)

30

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studiesteder

      • Cairo, Egypt, 11351
        • Faculty of physical therapy cairo university
        • Ta kontakt med:

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Barn

Tar imot friske frivillige

Nei

Beskrivelse

Inclusion Criteria:

  • Their age will range from 7 to 12 years.
  • The degree of their spasticity will range from 1 to 1+ according to Modified Ashworth' Scale (Bohannon et al., 1987) (Appendix IⅠ).
  • They will be on level Ⅰ or Ⅱ on GMFCS (Palisano et al., 2007) (Appendix IⅡ).
  • They will be able to walk without the use of an assistive device
  • Children can follow instructions and understand given orders.

Exclusion Criteria:

  • Severe visual or hearing impairment.
  • Fixed deformities or surgical interventions in the lower extremities.
  • Botulinum toxin injections in the last 6 months.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Study Group
  • Conventional physical therapy program
  • Steadys Biofeedback Gait Training system
Participants receive gait training using the Steadys biofeedback gait training system for 30 minutes, three times per week for three consecutive months. The system uses wearable inertial measurement unit (IMU) sensors to provide real-time visual and auditory biofeedback while the child walks on a treadmill, enabling correction of abnormal gait patterns and improvement of gait symmetry.
Conventional physical therapy program for 30 minutes, three times per week for three consecutive months, including mat activities, standing exercises, and training of righting, equilibrium, and protective reactions.
Aktiv komparator: Control Group
  • Conventional physical therapy program
  • Traditional gait training
Conventional physical therapy program for 30 minutes, three times per week for three consecutive months, including mat activities, standing exercises, and training of righting, equilibrium, and protective reactions.
Traditional gait training for 30 minutes, three times per week for three consecutive months, including walking on a balance beam, balance board, stepper, and separator.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Gait cycle time
Tidsramme: Baseline and immediately after completion of the 3-month intervention.
Change in gait cycle time measured using the Steadys gait analysis system with inertial measurement unit (IMU) sensors during a 10-meter walking test.
Baseline and immediately after completion of the 3-month intervention.
Step time
Tidsramme: Baseline and immediately after completion of the 3-month intervention.
Change in step time measured using the Steadys gait analysis system with inertial measurement unit (IMU) sensors during a 10-meter walking test.
Baseline and immediately after completion of the 3-month intervention.
Cadence
Tidsramme: Baseline and immediately after completion of the 3-month intervention.
Change in cadence (steps/minute) measured using the Steadys gait analysis system with inertial measurement unit (IMU) sensors during a 10-meter walking test.
Baseline and immediately after completion of the 3-month intervention.
Stance phase
Tidsramme: Baseline and immediately after completion of the 3-month intervention.
Change in stance phase duration (% of the gait cycle) measured using the Steadys gait analysis system with inertial measurement unit (IMU) sensors during a 10-meter walking test.
Baseline and immediately after completion of the 3-month intervention.
Single support
Tidsramme: Baseline and immediately after completion of the 3-month intervention.
Change in single support duration (% of the gait cycle) measured using the Steadys gait analysis system with inertial measurement unit (IMU) sensors during a 10-meter walking test.
Baseline and immediately after completion of the 3-month intervention.
Double support
Tidsramme: Baseline and immediately after completion of the 3-month intervention.
Change in double support duration (% of the gait cycle) measured using the Steadys gait analysis system with inertial measurement unit (IMU) sensors during a 10-meter walking test.
Baseline and immediately after completion of the 3-month intervention.
Swing phase
Tidsramme: Baseline and immediately after completion of the 3-month intervention.
Change in swing phase duration (% of the gait cycle) measured using the Steadys gait analysis system with inertial measurement unit (IMU) sensors during a 10-meter walking test.
Baseline and immediately after completion of the 3-month intervention.
Stride length
Tidsramme: Baseline and immediately after completion of the 3-month intervention.
Change in stride length (cm) measured using the Steadys gait analysis system with inertial measurement unit (IMU) sensors during a 10-meter walking test.
Baseline and immediately after completion of the 3-month intervention.
Gait speed
Tidsramme: Baseline and immediately after completion of the 3-month intervention.
Change in gait speed measured using the Steadys gait analysis system with inertial measurement unit (IMU) sensors during a 10-meter walking test.
Baseline and immediately after completion of the 3-month intervention.
Foot clearance
Tidsramme: Baseline and immediately after completion of the 3-month intervention.
Change in foot clearance (cm) measured using the Steadys gait analysis system with inertial measurement unit (IMU) sensors during a 10-meter walking test.
Baseline and immediately after completion of the 3-month intervention.
Swing width
Tidsramme: Baseline and immediately after completion of the 3-month intervention.
Change in swing width (cm) measured using the Steadys gait analysis system with inertial measurement unit (IMU) sensors during a 10-meter walking test.
Baseline and immediately after completion of the 3-month intervention.

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

30. juni 2026

Primær fullføring (Antatt)

30. september 2026

Studiet fullført (Antatt)

1. desember 2026

Datoer for studieregistrering

Først innsendt

26. juni 2026

Først innsendt som oppfylte QC-kriteriene

1. juli 2026

Først lagt ut (Faktiske)

6. juli 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

6. juli 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

1. juli 2026

Sist bekreftet

1. juli 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

IPD-planbeskrivelse

Individual participant data (IPD) will not be shared because there is no plan to make de-identified participant-level data publicly available.

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere